SUBSCRIBE
SUBSCRIBE

Alkermes

NEWS
Policy
FDA Eyes Safety Of Popular Anemia Drugs
October 19, 2005
 · 
1 min read
Business
ConjuChem
October 19, 2005
 · 
8 min read
Biotech Moves Ahead Of Major Indexes
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Alkermes to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 6, 2021
 · 
1 min read
Business
Alkermes Announces Updates to Executive Leadership Team
January 6, 2021
 · 
6 min read
FDA Accepts Alkermes’ Resubmission of New Drug Application for ALKS 3831
December 29, 2020
 · 
6 min read
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
December 10, 2020
 · 
13 min read
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
November 17, 2020
 · 
8 min read
Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
November 9, 2020
 · 
11 min read
Business
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET
October 29, 2020
 · 
1 min read
Business
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
October 29, 2020
 · 
19 min read
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
October 9, 2020
 · 
7 min read
Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831
October 7, 2020
 · 
6 min read
Load More